Grošelj Uroš, Golobič Amalija, Knez Damijan, Hrast Martina, Gobec Stanislav, Ričko Sebastijan, Svete Jurij
Faculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, 1000, Ljubljana, Slovenia.
Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000, Ljubljana, Slovenia.
Mol Divers. 2016 Aug;20(3):667-76. doi: 10.1007/s11030-016-9668-9. Epub 2016 Mar 26.
The synthesis of two novel (+)-isocampholenic acid-derived amines has been realized starting from commercially available (1S)-(+)-10-camphorsulfonic acid. The novel amines as well as (+)-isocampholenic acid have been used as building blocks in the construction of a library of amides using various aliphatic, aromatic, and amino acid-derived coupling partners using BPC and CDI as activating agents. Amide derivatives have been assayed against several enzymes that hold potential for the development of new drugs to battle bacterial infections and Alzheimer's disease. Compounds 20c and 20e showed promising selective sub-micromolar inhibition of human butyrylcholinesterase [Formula: see text] ([Formula: see text] values [Formula: see text] and [Formula: see text], respectively).
从市售的(1S)-(+)-10-樟脑磺酸出发,实现了两种新型(+)-异龙脑烯酸衍生胺的合成。这些新型胺以及(+)-异龙脑烯酸已被用作构建酰胺库的基础原料,使用各种脂肪族、芳香族和氨基酸衍生的偶联伙伴,以BPC和CDI作为活化剂。已针对几种在开发对抗细菌感染和阿尔茨海默病的新药方面具有潜力的酶对酰胺衍生物进行了测定。化合物20c和20e对人丁酰胆碱酯酶表现出有前景的选择性亚微摩尔抑制作用化学式:见原文。